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ABSTRACT 
Objective: To examine the effect of regular moderate intensity exercise (3 training 
sessions/week) on the incidence of gestational diabetes mellitus (GDM, primary outcome). 
We also examined if the exercise intervention modifies the association between GDM and 
birth weight and risk of macrosomia, gestational age, risk of caesarean delivery, and maternal 
weight gain (secondary outcomes).  
Methods. We randomly assigned 510 healthy gravidae to either an exercise intervention or a 
usual care (control) group (n=255 each). The exercise program focused on moderate 
resistance and aerobic exercises (3 times per week, 50-55 min per session). GDM diabetes 
was diagnosed according to the World Health Organization (WHO) criteria and the 
International Association for Diabetes in Pregnancy Study Group (IADPSG). 
Results: The intervention did not reduce the risk of developing GDM (OR:0.84, 
95%CI:0.503-1.395), when using the WHO criteria. We observed that the intervention 
reduced by 58% the GDM-related risk (WHO criteria) of having a newborn with macrosomia 
(OR: 1.76, 95%CI:0.039-78.851 vs. 4.22, 95%CI:1.349-13.191) in exercise and control 
groups, respectively), and by 34% the GDM-related risk of having acute and elective 
caesarean delivery (OR: 1.30,  95%CI:0.443-3.844vs. 1.99, 95%CI:0.976-4.059 in exercise 
and control groups, respectively). Gestational age was similar across treatment groups 
(control, exercise) and GDM category (GDM or non-GDM), and maternal weight gain was 
~12% lower in the exercise group independently of whether women developed GDM. The 
results were similar when the IADPSG criteria were used instead. 
Conclusions: Regular moderate-intensity exercise performed over the second-third trimesters 
of pregnancy can be used to attenuate important GDM-related adverse outcomes.  
Key words: Exercise, pregnancy, gestational diabetes, macrosomia. 
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INTRODUCTION 
Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy 
1. GDM substantially increases the risk of short and long-term adverse health outcomes for 
both the mother and the offspring 2 3. The GDM-related adverse maternal outcomes include an 
increased risk for perinatal morbidity, impaired glucose tolerance and type 2 diabetes after 
pregnancy, and caesarean delivery 3-6. Offspring of women with GDM are at higher risk of 
macrosomia 1 7, and also at higher risk of being obese and having impaired glucose tolerance 
or diabetes in childhood and early adulthood 1. There is an association of fasting maternal 
glucose levels, even if below those diagnostic of GDM, with birth weight and cord-blood 
serum C-peptide levels 8.  
Efforts for combating GDM and GDM-related complications should be thus 
maximized. Higher levels of physical activity before pregnancy (included vigorous sports 
activity) 9 or in early pregnancy are associated with a lower risk of developing GDM, as 
shown in a recent meta-analysis including a total of 34,929 participants with 2,855 cases of 
GDM 2. Previous randomized controlled trials (RCT) have shown that exercise during 
pregnancy induced normalization of glycemia in pregnant women 10, or was effective in 
reducing the number of patients with GDM who required insulin and in improving glycemic 
control 11. However, an exercise intervention did not seem sufficient to prevent GDM in obese 
pregnant women 12, and Stafne et al. 13 found no evidence that an exercise program performed 
during the second half of pregnancy prevented GDM or improved insulin resistance in healthy 
pregnant women with normal body mass index. 
Besides the aforementioned controversy regarding the actual effects of exercise 
performed during pregnancy on GDM prevention, no RCT has been conducted to assess 
whether exercise can attenuate the potential GDM-related complications, such as macrosomia, 
caesarean delivery, gestational age, and maternal weight gain 3. To better understand whether 
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regular exercise during pregnancy can be used to combat GDM-related outcomes is of clinical 
relevance and of public health interest.  
The aim of the present RCT was to examine the effect of regular moderate intensity 
exercise (3 training sessions/week) performed during the second and third trimesters of 
pregnancy on the incidence of GDM (primary outcome). We also examined if the exercise 
intervention modifies the association between GDM and several mother/offspring 
characteristics on which this disorder is known to have a negative impact 3, that is, birth 
weight and risk of macrosomia, gestational age, risk of caesarean delivery, and maternal 
weight gain (secondary outcomes).  
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METHODS 
The present RCT (registration trial number: NCT01477372) was conducted between 
September 2007 and January 2011 following the ethical guidelines of the Declaration of 
Helsinki, last modified in 2000. The research protocol was reviewed and approved by the 
Hospital Severo Ochoa (Madrid, Spain).  
Participants and randomization 
We contacted a total of 780 Spanish pregnant women (of Caucasian descent for three or more 
generations) from a primary care medical centre (Centro de Los Pedroches and Centro de 
Salud Leganés Norte, Leganés, Madrid, Spain) (Figure 1). Inclusion criteria included: being 
sedentary (not exercising >20 minutes on >3 days per week), with singleton and 
uncomplicated gestation, and not at high risk for preterm delivery (i.e. ≤ one previous preterm 
delivery). For practical reasons, women not planning to give birth in the same obstetrics 
hospital department (Hospital Severo Ochoa, Madrid, Spain), and not being under medical 
follow-up throughout the entire pregnancy period were not included in the study, neither were 
women having any serious medical condition that prevented them from exercising safely 14.  
After women provided written informed consent, we randomly assigned 510 healthy 
gravidae to either an exercise intervention (n=255) or a usual care (control, n=255). The 
participant randomization assignment followed an allocation concealment process, that is, the 
researcher in charge of randomly assigning participants did not know in advance which 
treatment the next person would receive and did not participate in the assessments. 
Assessment staff was blinded to participant randomization assignment. Participants were 
explicitly informed of the group to which they were assigned as well as on the study 
hypotheses and were reminded not to discuss their randomisation assignments with 
assessment staff. Because of the nature of the study, it was not be possible to conceal the 
group assignment from the staff involved in exercise training sessions. To reduce participants 
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drop out and to maintain adherence to the training program, all sessions were accompanied 
with music, and were performed in an airy, well lighted exercise room at the Hospital. A 
qualified fitness specialist carefully supervised every training session with the assistance of an 
obstetrician and worked with groups of 10-12 women.  
Exercise intervention 
The interventions were performed in waves so that each wave had between 10 and 12 
participants in the intervention group, and 10-12 in the usual care group. The exercise 
intervention group trained 3 days/week (Monday, Wednesday, Friday, 50-55 min per session) 
from weeks 10–12 of pregnancy to the end of the third trimester (weeks 38–39). Thus, an 
average of 85 training sessions was originally planned for each participant in the event of no 
preterm delivery. The intervention involved aerobic exercises, muscle strength, and 
flexibility, and met the standards of the American College of Obstetricians and Gynecologists 
15 16. Women used a heart rate (HR) monitor (Accurex Plus, Polar Electro OY, Finland) during 
the training sessions to ensure that exercise intensity was moderate; their HR was consistently 
under 70% of their age-predicted maximum HR value (220 minus age, in years). Intensity was 
also controlled by the Borg’s conventional (6-20 point) scale [41]. Exercise intensity 
expressed as rate of perceived exertion (RPE)] ranged from 10 to 12. These RPE values 
correspond to a subjective perceived exertion of “farily light” and “somewhat hard” 
respectively. 
 
The main part of the session included a 25-30 min which was preceded and followed by a 
gradual warm-up and cool-down period respectively (both of 10-12 min duration and 
consisting of walking and light, static stretching (avoiding muscle pain) of most muscle 
groups (upper and lower limbs, neck and trunk muscles). The cool-down period also included 
relaxation and pelvic floor exercises.  
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The main part of the session included the following moderate resistance exercises: 
toning and joint mobilization exercises, i.e. shoulder shrugs and rotations, arm elevations, leg 
lateral elevations, pelvic tilts and rocks. Resistance exercises were performed through the full 
range of motion normally associated with correct technique for each exercise and engaged the 
major muscle groups (pectoral, back exercise, shoulder, upper and lower limb muscles). It 
included one set (10–12 repetitions of each) of i) pelvic tilting in standing and ii) the 
following exercises using barbells (3 kg/exercise) or low-to-medium resistance (elastic) bands 
(Therabands): biceps curls, arm extensions, arm side lifts, shoulder elevations, bench press, 
seated lateral row, lateral leg elevations, leg circles, knee extensions, knee (hamstring) curls, 
ankle flexion and extensions. We specifically avoided any exercise that involved extreme 
stretching and joint overextension, ballistic movements or jumps, and exercises in supine 
position on the floor were not performed for more than 2 minutes. We used exercises covering 
the major muscle groups of arms and abdomen to promote good posture, prevent low back 
pain and strengthen the muscles of labor and pelvic floor (third trimester). We also included 
in the program one session per week of aerobic dance. We used choreography involving upper 
and lower body limbs of very low impact. Aerobic dance activities were developed in sections 
of 3-4 minutes with 1 minute breaks which included stretching and relaxation activities. 
Usual care (control) group 
Women randomly assigned to the usual care (control) group received general advice from 
their midwife about the positive effects of physical activity. Participants in the usual care 
group had their usual visits with health care providers (midwives, obstetricians and family 
doctors) during pregnancy, which was equal as in the exercise group. Women were not 
discouraged from exercising on their own.  
Participants’ demographics 
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Demographic information was obtained at study entry. Pregravid weight was based on a self-
report at the time of the study enrollment. Heights were measured by trained research staff at 
study entry. Body mass index was calculated as weight in kg divided by height in meters 
squared. 
Outcomes 
Primary outcome. Women underwent a 75-g oral glucose tolerance test (OGTT) at 24-26th 
week, after an overnight fasting. Glycemia was measured 2 hours after the OGTT (hereafter 
called 2h-glucose) with the routine methods used by the hospital laboratory. GDM diabetes 
was diagnosed according to the two accepted criteria 3: (i) the World Health Organization 
(WHO) criteria, i.e. 2-h glucose  ≥140 mg/dl; and (ii) the International Association for 
Diabetes in Pregnancy Study Group (IADPSG), i.e. 2-h glucose ≥153 mg/dl. The diagnosed 
GDM patients received advice on a 2.000kcal diet, metabolic controls twice a day (by 
themselves or in the hospital), obstetric care considering high-risk pregnancy, and were also 
recommended to perform physical activity.  
Secondary outcomes. Gestational body weight gain was calculated on the basis of the 
pregravid weight and weight at the last clinic visit before delivery. We recorded birth weight 
of the newborn from hospital perinatal records. Newborns were classified as having 
macrosomia when birth weight was >4,000g. We obtained Apgar scores (at 1 and 5 minutes) 
as well as gestational age at time of delivery and cesarean deliveries (both acute and elective) 
from the reports of delivery room personnel (midwives). 
Statistical analysis 
We made power calculations for the primary outcome measures of GDM following the WHO 
criteria assuming a GDM prevalence in our population using previous studies conducted in 
the same hospital 17 of ~25%  in the intervention group and 30% in the usual care group (risk 
difference of 5-10%)  Under these assumptions, a two-sample comparison (χ2) with a 5% 
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level of significance and a statistical power of 0.80 gave a study population of ~200 patients 
in each group. Assuming a maximum lost to follow-up of 10%, we needed to include 
approximately 220 women for each group at baseline.  
For treatment group comparisons, we analysed continuous and nominal data with 
Student’s t test for unpaired data and Chi-square tests, respectively. We used logistic 
regression analysis to examine the effect of the exercise intervention on the incidence of 
GDM (primary outcome) as assessed with the WHO and IADPSG criteria, after controlling 
for maternal age and body weight prior to pregnancy. We also used logistic regression 
analysis to examine the effect of treatment group (training and control) and GDM category 
(non-GDM or GDM gravidae) and their interaction, on the likelihood of having a newborn 
with macrosomia and on the likelihood of cesarean deliveries (secondary outcomes), after 
controlling for maternal age, body weight prior to pregnancy, and gestational age. Analysis of 
covariance was used to examine the effect of treatment group and GDM category and their 
interaction, on birth weight, gestational age, and gestational weight gain (secondary outcome), 
after controlling for maternal age, and body weight prior to pregnancy. We conducted all 
statistical analyses using the Statistical Package for Social Sciences (SPSS, v. 18.0 for 
WINDOWS; SPSS Inc, Chicago), and the level of significance was set to ≤ 0.05. 
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RESULTS  
In the training group a total of 45 participants were lost to follow-up due to premature labour 
(n=5), pregnancy-induced hypertension (n=5), persistent bleeding (n=3), or personal reasons 
(n=32). In the control group, a total of 37 were lost to follow-up due to premature labour 
(n=3), pregnancy-induced hypertension (n=4), molar pregnancy (n=3), and personal reasons 
(n=16). Eleven participants from the same group were also lost to follow-up because they 
decided to give birth in a different hospital. Thus, no primary outcome data are available for 
analysis in this group of women, and no missing data was imputed. Therefore, final number of 
participants included in the per protocol analysis was 210 in the training group and 218 in the 
control group (Figure 1). There were no exercise-related injuries experienced during 
pregnancy. Demographic characteristics of participants included in both the training and 
control group were similar to those of the participants who discontinued the program (all 
P>0.1, data not shown). Adherence to training in the experimental group was >95%. No 
participant changed from the control group to the intervention group or vice versa, and there 
were no protocol deviations from study as planned.  
Maternal and newborn characteristics in the exercise and usual care groups are shown 
in Table 1. 2-h glucose was significantly higher (~6%, P=0.012) in the control group. 
Maternal weight gain was significantly lower (~13%, P<0.001) in the exercise group. Birth 
weight, Apgar score at minutes 1 and 5, and gestational age were similar in both groups. 
The OR of having GDM (WHO criteria) was significantly lower in the exercise group 
(OR: 0.62, 95% CI: 0.398-0.981, P=0.041) (Figure 2), yet the association was attenuated once 
maternal age and body weight prior to pregnancy were included as covariates (OR: 0.84, 95% 
CI: 0.503-1.395, P=0.496). The results were similar when using the IADPSG diagnostic 
criteria (OR: 0.90, 95% CI: 0.524-1.565, P=0.722).  
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The effects of treatment group and GDM (using both WHO and IADPSG diagnostic 
criteria) on pregnancy outcomes are shown in Table 2. Following the WHO criteria to 
diagnose GDM, birth weight was similar in both exercise and control groups in women with 
no GDM, yet in women with GDM, birth weight was significantly lower (~7%, P=0.014) in 
the exercise group (P-value for treatment*GDM group interaction = 0.025). The OR of 
having a newborn with macrosomia was significantly lower in the exercise group in both non-
GDM and GDM gravida (OR in non-GDM gravida: 0.10, 95%CI: 0.011-0.949, P=0.045; OR 
in GDM-gravida: 0.07, 95%CI: 0.05-0.932, P=0.044) after controlling for maternal age, body 
weight prior to pregnancy and gestational age (P-value for treatment*GDM group interaction 
= 0.981). Gestational age was similar in both exercise and control groups as well as in non-
GDM and GDM gravida (all P>0.1). Maternal weight gain was lower (~12%, P<0.05) in the 
exercise group in both non-GDM and GDM gravida (P-value for treatment*GDM group 
interaction = 0.536).  
In the control group, GDM gravida (diagnosed following the WHO criteria) had an 
increased OR of having a newborn with macrosomia compared with non-GDM gravida (OR: 
4.22, 95% CI: 1.349-13.191; P=0.013), whereas no association was found between GDM and 
risk of macrosomia in the GDM gravida of the exercise group (OR: 1.76, 95% CI: 0.039-
78.851; P=0.770) (Figure 2). In the control group, GDM gravida (diagnosed following the 
WHO criteria) had an increased OR of cesarean delivery (both acute and elective) compared 
with non-GDM gravida (OR: 1.99, 95% CI: 0.976-4.059; P=0.058), whereas no association 
was observed between GDM and risk of cesarean delivery in the GDM gravida of the exercise 
group (OR: 1.30, 95% CI: 0.443-3.844; P=0.630). The findings persisted after further 
adjusting for gestational weight gain (data not shown). The results were similar when the 
IADPSG criteria were used instead. 
 
12 
 
DISCUSSION 
The present study showed that supervised, moderate intensity exercise intervention performed 
three times per week over the second and third trimesters of pregnancy in previously 
sedentary and healthy gravida did not reduce the risk of developing GDM, yet it reduced by 
58% the GDM-related risk of having a newborn with macrosomia (OR: 1.763 vs. 4.219 in 
exercise and control groups, respectively), and by 34% the GDM-related risk of having 
caesarean delivery (OR: 1.304 vs. 1.990 in exercise and control groups, respectively). A third 
main finding was that gestational age was similar across treatment groups (control, exercise) 
and GDM category (GDM or non-GDM), whereas maternal weight gain was ~12% lower in 
the exercise group independently of whether women developed GDM. The fact that the 
results were similar when using the WHO or the IADPSG criteria to define GDM further 
strengthens the study findings. 
 Exercise performed during early pregnancy is associated with a lower risk of 
developing GDM 18, as shown in previous prospective cohort 19-22, retrospective case-control 
22 23, or cross-sectional surveys 24 25. More recently, Hopkins et al. 26 showed that a home-
based stationary cycling program from 20 wk did not affect maternal insulin sensitivity in late 
gestation. Earlier intervention studies also showed the benefits of exercise performed during 
the pregnancy period on maternal and offspring health. Jovanovic-Peterson and Peterson 27 
reported that pregnant women with GDM receiving an exercise therapy had greater glycemic 
control and improved cardiorespiratory fitness compared with their peers receiving a standard 
dietary intervention. There is however no unanimity among more recent findings from RCT. 
We recently showed that in healthy pregnant women, exercise training combining land and 
aquatic activities performed during the entire pregnancy induced normalization of glycemia 
10. In a study on pregnant women with GDM, a moderate-intensity resistance training program 
using elastic bands was effective in reducing the number of patients who required insulin and 
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in improving their glycemic control 11. However, in obese pregnant women, an exercise 
intervention over pregnancy (with an energy expenditure goal of 900 kcal/week) was not 
sufficient to prevent GDM 12. Furthermore, Stafne et al. 13 found no evidence that an exercise 
program performed during the second half of pregnancy prevented GDM or improved insulin 
resistance in healthy pregnant women with normal body mass index.  
An important novel finding of our study was that moderate-intensity exercise 
performed during pregnancy significantly reduced the risk of GDM-related complications, 
notably macrosomia. We observed that the OR of having a newborn with macrosomia was 
reduced by 58% in the GDM-gravida from the training group compared with the GDM-
gravida from the control group. This finding is of public health relevance because fetal 
macrosomia is associated with significant maternal and neonatal morbidity 28. In the long 
term, macrosomic babies are more likely to be obese in childhood, adolescence and early 
adulthood, and are at higher risk of cardiovascular and metabolic complications in adulthood 
28. High birth weight is also associated with an increased risk of overall leukemia and acute 
myeloid leukemia 29. Glucose intolerance due to increased insulin resistance tends to develop 
during pregnancy 30. This facilitates continuous glucose transfer to the fetus. In contrast, 
exercise training enhances insulin sensitivity in the exercised muscle and enhances muscle 
contraction-induced glucose uptake in this tissue 31. Therefore, it can be hypothesized that the 
risk of macrosomia would be reduced under a “physically active” milieu 32.   
GDM/hyperglycemia is also known to increase the risk of cesarean delivery 8 33. A 
recent meta-analysis showed significantly higher risk of cesarean delivery associated with 
GDM 3. In the present RCT, we observed that the OR having cesarean delivery was reduced 
by 34% in the GDM gravida from the training group compared with the GDM gravid from the 
control group. We believe this result is also of potential clinical relevance owing to the 
maternal complications associated with cesarean delivery such as infection, excessive blood 
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loss, respiratory complications, reactions to anaesthesia, longer hospitalization periods, as 
well as higher medical cost 34.  
A third main finding of our study was that gestational age was similar across groups 
(control or exercise) and conditions (GDM or no GDM), whereas maternal weight gain was 
~12% lower in the exercise group independent of whether the women had GDM. There is 
compelling evidence that physical activity during pregnancy has no major effect on 
gestational age at delivery. In a previous RCT, we showed that resistance training during 
pregnancy on previously sedentary, healthy women carrying singletons did not alter 
gestational age at delivery compared with inactive controls 35. Taken together, these findings 
support the notion that healthy pregnant women, without contraindications to physical 
activity, are able to engage in these active behaviours without undue risk of preterm birth. 
Excessive weight gain during pregnancy is a major risk factor for postpartum weight 
retention and future weight gain and obesity in women 36.  Maternal weight gain, especially in 
early in pregnancy, is disproportionately fat and could influence subsequent maternal insulin 
resistance 37. Yet few adequately powered RCTs have examined the efficacy of behavioural 
weight-control interventions during pregnancy. Results from RCT 38-40{Haakstad, 2011 
#4795} showed decreases in maternal weight gain with a behavioural intervention combining 
nutritional and physical activity recommendations. A recent relatively small RCT (total n=83) 
showed a trend towards a decrease (-9%) in maternal weight gain with exercise 10. Haakstad 
and Bø {Haakstad, 2011 #4795} showed that women attending all sessions of the prescribed 
exercise program (n=24 exercise sessions) training program had a higher weight reduction of 
(2.8kg) compared with women in the control group.  
A limitation of the current study was that we did not record detailed information about 
the participants’ dietary habits despite women with GDM were advised to follow a dietary 
regimen. Further, pre-pregnancy weight was self-reported which might be slightly 
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underestimated. We did not closely follow the physical activity levels of women in the control 
group, yet they all reported that they did not engage in any regular physical activity program 
for more than 20 minutes on more than 3 days per week. It cannot be discard that both diet 
and physical activity advice delivered to the GDM women might have influence the results of 
the present study. Yet, both women in the exercise group and those in the usual care group 
that developed GDM receive a similar type of recommendations.  
In summary, although regular exercise performed over the second and third trimesters 
of pregnancy did not actually reduce the risk of GDM, a major finding of our study was that, 
besides reducing maternal weight gain by 12% in non-GDM, exercise intervention 
ameliorated by 58% the impact of GDM on the risk of macrosomia and by 34% the GDM-
related risk of having caesarean delivery. Of note is that the magnitude of the associations was 
similar when using WHO or the IADPSG criteria to define GDM, which is an additional 
strength to the study results. Taken together, our findings provide further support for the 
benefits of moderate exercise in healthy gravida and for promoting supervised exercise 
interventions during pregnancy 32 41.  
 
What are the new findings 
A supervised, moderate intensity exercise intervention performed three times per week over 
the second and third trimesters of pregnancy in previously sedentary and healthy gravida: 
- Reduced the GDM-related risk of having a newborn with macrosomia. 
- Reduced the GDM-related risk of having caesarean delivery 
How might it impact on clinical practice in the near future 
The study provide further evidence about the potential benefits of moderate exercise in 
healthy gravida, as well as in gravida with gestational diabetes mellitus.  Taken together, these 
findings reinforce the idea of promoting supervised exercise interventions over pregnancy. 
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Table 1. Characteristics in the exercise and usual care (control) groups.  
 
 
Data are expressed as mean±SD, unless otherwise indicated. 
We analyzed continuous and nominal data with t test for unpaired data and Chi-square tests 
respectively.  
Abbreviation: GDM, gestational diabetes mellitus. 
World Health Organization (WHO) criteria when 2 hours 75 g oral glucose tolerance test (‘2-
h glucose’) ≥140 mg/dl. GDM International Association for Diabetes in Pregnancy Study 
Group (IADPSG) criteria when 2-h glucose ≥153 mg/dl. 
 Exercise  (n=210) 
Control 
(n=218) P 
Maternal characteristics    
Maternal age (years) 31 ± 3 31 ± 4 0.906 
Body mass index (kg/m2) 24.1 ± 4.1 23.7 ± 3.8 0.354 
Occupational activity (n, %)   0.422 
Sedentary job  73 (34.8) 85 (39)  
House wives  56 (26.7) 62 (28.4)  
Active job  81 (38.6) 71 (32.6)  
Maternal education (n, %)   0.108 
 <High school 54 (25.7) 75 (34.4)  
   High school 98 (46.7) 96 (44)  
 >High school 58 (27.6) 47 (21.6)  
Weight gain during pregnancy (kg) 11.6 ± 3.7 13.3 ± 4.1 <0.001 
2-h glucose (mg/dl) 116.8 ± 29.8 123.86 ± 28.6 0.012 
GDM WHO criteria* (n, %)  41 (19.5) 61 (28) 0.040 
GDM IADPSG criteria** (n, %)  29 (13.8) 32 (14.7) 0.797 
Newborn characteristics    
Birth weight (g) 3,201 ± 446 3,257 ± 469 0.208 
Macrosomia (birth weight >4,000g 
(n, %) 2 (1) 15 (6.9) 0.002 
Apgar score 1 min  8.8 ± 1.4 8.7 ± 1.3 0.313 
Agpar score 5 min 9.9 ± 0.5 9.9 ± 0.7 0.292 
Gestational age (days) 277 ± 11 277 ± 10 0.942 
Cesarean delivery (n, %) 33 (15.7) 45 (20.6) 0.187 
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Table 2. Effect of treatment group and gestational diabetes mellitus (GDM) on pregnancy 
outcomes.  
 no GDM (WHO criteria)  GDM (WHO criteria) 
 
  Exercise  (n=169) 
Control  
(n=157)  
Exercise  
(n=41) 
Control 
 (n=61) P
* 
Birth weight (g) 3200 ± 442 3191 ± 470  3204 ± 470 3429 ± 427
‡ 0.025 
Gestational age (days) 277 ± 12 276 ± 10  276 ± 11 279 ± 8 0.137 
Cesarean delivery (n, %) 24 (14.2) 28 (17.8)  9 (22) 17 (27.9) 0.934 
Maternal weight gain (kg) 11.8 ± 3.6 13.3 ± 4.3†  11.2 ± 4.1 13.3 ± 3.7
^ 0.536 
Apgar score 1 min 8.8 ± 1.4 8.6 ± 1.4  8.8 ± 1.3 8.9 ± 1.2 0.347 
Apgar score 5 min 9.9 ± 0.4 9.9 ± 0.4  9.8 ± 0.7 10 ± 1.2 0.10 
 no GDM (IADPSG criteria)  GDM (IADPSG criteria)  
  Exercise  (n=181) 
Control  
(n=186)  
Exercise  
(n=29) 
Control 
 (n=32) P
* 
Birth weight (g) 3204 ± 444 3218 ± 465  3180 ± 465 3482 ± 437
^ 0.022 
Gestational age (days) 277 ± 10 277 ± 11  280 ± 7 277 ± 11 0.261 
Cesarean delivery (n, %) 27 (14.9) 36 (19.4)  6 (20.7) 9 (28.1) 0.891 
Maternal weight gain (kg) 11.7 ± 3.7 13.3 ± 4.2†  11.6 ± 4.1 13.4 ± 3.8 0.902 
Apgar score 1 min 8.8 ± 1.4 8.6 ± 1.4  8.9 ± 1.1 8.9 ± 0.2 0.668 
Apgar score 5 min 9.8 ± 0.5 9.9 ± 0.8  9.8 ± 0.5 9.9 ± 0.8 0.768 
 
Abbreviation: GDM, gestational diabetes mellitus. 
World Health Organization (WHO) criteria when 2 hours 75 g oral glucose tolerance test (‘2-
h glucose’) ≥140 mg/dl. GDM International Association for Diabetes in Pregnancy Study 
Group (IADPSG) criteria when 2-h glucose ≥153 mg/dl. 
*P for treatment (group) x GDM interaction.  
‡P<0.05 vs. exercise group. 
^P<0.01 vs. exercise group.  
†P<0.001 vs. exercise group. 
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Figure legends 
Figure 1. Flow diagram of the study participants. 
Figure 2. Percentage (within brackets) of newborns with birth weight >4,000g (panel A) and 
percentage of caesarean delivery (panel B) by treatment and gestational diabetes mellitus 
(GDM) criteria: GDM, GDM World Health Organization (WHO) criteria when glycemia 2 
hours after a 75 g oral glucose tolerance test ≥140 mg/dl. GDM International Association for 
Diabetes in Pregnancy Study Group (IADPSG) criteria when glycemia 2 hours after a 75 g 
oral glucose tolerance test ≥153 mg/dl. Control group GDM gravida diagnosed following the 
WHO criteria had an increased odds ratio (OR) of having a newborn with macrosomia 
compared with non-GDM gravida (OR: 4.22, 95% CI: 1.349-13.191; P=0.013), whereas no 
association was found between GDM and risk of macrosomia in the exercisers GDM gravida 
(OR: 1.76, 95% CI: 0.039-78.851; P=0.770) after controlling for maternal age and body 
weight prior to pregnancy (Panel A). Control group GDM gravida had an increased OR of 
cesarean delivery (both acute and elective) compared with non-GDM gravida (OR: 1.99, 95% 
CI: 0.976-4.059; P=0.058), whereas no association was observed between GDM and risk of 
cesarean delivery in the exercisers GDM gravida (OR: 1.30, 95% CI: 0.443-3.844; P=0.630). 
The results were similar when the IADPSG criteria were used instead (Panel 2B). 
 
